| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 8e-05 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |